Coming Soon

Season 1: Network Effects
Unlock exponential growth
Master the 16 network effects
20 years of insights in one class

Investing Profile

Vikas Goyal

Photo of Vikas Goyal, Principal at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
159 CONNECTIONS
University of Pennsylvania Network
96 CONNECTIONS
McKinsey & Company Network
90 CONNECTIONS
The Wharton School Network
61 CONNECTIONS
cb
SR One Principal
7
CompanyStageDateRound SizeTotal Raised
Pandion Therapeutics
Series AJan 2018$58M
$140M
Co-investors: Alan Crane (Polaris Partners), Dan Becker (Access Biotechnology), Carlo Rizzuto (Versant Ventures)
Spero Therapeutics
Series CMar 2017$52M
Series BFeb 2016$30M
Series AJun 2015$30M
$110M
Co-investors: Michael Gladstone (Atlas Venture), Jean-François Formela (Atlas Venture)
CalciMedica
Series CDec 2009$12M
Series CJan 2009$4M
Series AJul 2007$1.5M
$18M
Associate SR One2011 - Present
Manager, Corporate Strategy & Development Infinity Pharmaceuticals2010 - 2011
Intern SR One2009 - 2010
Co-Chair TiE Social Entrepreneurs2006 - 2008
Senior Associate, Co-Founder Extera Partners2004 - 2008
Associate, PureTech Development PureTech Ventures2004 - 2007
Senior Analyst McKinsey & Company2001 - 2003
The Wharton School MBA Business
University of Pennsylvania MBA Health Care Management
Harvard University BA Neurobiology